PATENT CLAIM ANALYSIS

Application Number: 16111158
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["424", "174100"]

Abstract:
The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.

Claim (Index 17):
A method of treating cancer, the method comprising the step of administering a pharmaceutical composition of  claim 16  to a subject in need thereof, wherein the cancer is selected from the group consisting of kidney, breast, lung, kidney, bladder, urinary tract, urethra, penis, vulva, vagina, cervical, colon, ovarian, prostate, pancreas, stomach, brain, head and neck, skin, uterine, testicular, esophagus, and liver cancer.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 96.0
- Lexical Diversity: 1.5102
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15620771', '15328232', '15328225', '15744737', '16100019']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7604152944310199
- 35 USC 102 Novelty (BERT): 0.5937453670062051
- Combined Prediction Score: 0.7437483016885384
- Mean Citation Score: 479.97426400000006
- Max Citation Score: 535.1266
- Similarity Product: 428.8597420980453

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test